Bio-Rad Settles Lengthy Licensing Dispute
The dispute was originally between bioMérieux and Pasteur Sanofi Diagnostics, but the California-based research and diagnostics firm Bio-Rad acquired Pasteur Sanofi in 1999 and inherited the dispute.
As part of the settlement, announced Tuesday, France-based bioMérieux granted Bio-Rad a license to use its Epstein-Barr virus patents. The settlement amount is confidential, but Bio-Rad is anticipating a one-time impact on its revenue of $10 to $12 million in...
To view the full article, register now.